• PSKW/PDR Wins the PM360 2016 Trailblazer Award for EMR/EHR Initiative

    — PDR/PSKW Awarded Top Honors by PM360--Leading Industry Trade Magazine —


    PSKW/PDR, now ConnectiveRx, has accepted the 2016 Trailblazer Award for EMR/EHR Initiative from PM360, a leading health-marketing industry trade magazine.

    PM360 honors the bio/pharmaceutical industry's most influential leaders and innovators each year with the Trailblazer Awards. This year's honors were announced during the publication's annual event held in New York City on September 23.

    The Winner – EMR/EHR Initiatives Category
    EMR Coupons and Co-Pay Access

    As demand for financial assistance programs increases we strive to provide unprecedented access, coupled with programmatic depth and breadth, in order to meet the needs of HCPs and their patients, including providing access to affordability programs directly within EMRs.

    Through our relationships with connected EMR systems, we make financial assistance available to prescribers, patients, and pharmacists by integrating coupon and co-pay information into the ePrescribing module. Based on prescribers' actions taken in the EMR, our system produces patient-specific takeaway materials and integrates available financial offer information into printed and electronic prescriptions.

    » Contact us to start designing your next financial assistance program in EMR workflow

    Remaining on the Cutting Edge –
    Market Research Matters

    It is important to us to grow and evolve our services to meet the needs of their users and help motivate patients to start and stay on therapies. We have made it a priority this year to conduct a series of studies that examine prescribers' perceptions of, and attitudes toward, co-pay coupons, as well as ascertain the effectiveness of existing messaging programs. This research should assist with development of a series of best practices that can help our clients and partners craft the best messaging possible, with the ultimate aim of driving offer redemptions.

    The first round of results* revealed a few interesting points:
    • Prescribers overwhelmingly consider the cost of medications to their patient when prescribing.
    This makes generics the default treatment of choice, and generic alternatives with co-pay coupons 6x more preferential to those without.
    • 78% of prescribers surveyed recognize the benefits of co-pay coupons in encouraging patients to fill initial scripts as well as adhering to medications.
    • 64% of prescribers say they want the option to send e-coupons and print them for patients.
    The research supports our "mixed media" approach to in-workflow financial programs:
    1. Alert prescribers on-screen (using the PhysicianCare service)
    2. Hand something tangible to patients and/or make it available electronically if portals are an option (using eCopay and ScriptGuide services)
    3. Integrate with both printed and electronic scripts (using the eCopay service)
    To ensure that our connected EMRs can offer these affordability programs to prescribers and their patients with little pain and no cost, we provide step-by-step integration guidance, marketing support and revenue share models.

    Our bio/pharmaceutical sponsors benefit, too, as ScriptGuide/eCopay programs have been proven** to increase new prescription (NRx) fill rates and provide a healthy ROI.

    » Contact us to start designing your next financial assistance program in EMR workflow
    * Source: ConnectiveRx Co-Pay Prescriber Survey, Mar 2016, n=606
    ** Source: ConnectiveRx ConnectSys® Database
    NRx measurement is based on de-identified healthcare claims data at an Rx level. Results represent programs run since 2012 to December 2014. Respiratory includes Asthma and Allergy medications; Neurologic includes medications covering Depression, Parkinson's, Migraine etc. ROI measurement is based on de-identified healthcare claims data at an Rx level. Exact ROI Calculation may vary by brand depending on client driven assumptions. Results represent programs run since 2012 to December 2014. Respiratory includes Asthma and Allergy medications; Neurologic includes medications covering Depression, Parkinson's, Migraine etc. Based on non-specialty products